Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Símbolo desconocido
Fecha:
Ordernar por:
FechaHoraFuenteTítuloSímboloCompañía
06/08/202415:03Business WirePermian Resources Declares Quarterly Cash DividendNYSE:PRPermian Resources Corporation
06/08/202415:03Business WireReddit Announces Second Quarter 2024 ResultsNYSE:RDDTReddit Inc
06/08/202415:02GlobeNewswire Inc.Progyny, Inc. Announces Second Quarter 2024 ResultsNASDAQ:PGNYProgyny Inc
06/08/202415:02GlobeNewswire Inc.Inspire Medical Systems, Inc. Announces Second Quarter 2024 Financial Results and Updates 2024 OutlookNYSE:INSPInspire Medical Systems Inc
06/08/202415:02Business WirePorch Group Reports Second Quarter 2024 ResultsNASDAQ:PRCHPorch Group Inc
06/08/202415:02GlobeNewswire Inc.Olema Oncology Reports Second Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:OLMAOlema Pharmaceuticals Inc
06/08/202415:02Business WirePorch Group Files Reciprocal Exchange Application and Contributes PRCH Shares to HOA to Increase Surplus and Support Future GrowthNASDAQ:PRCHPorch Group Inc
06/08/202415:02PR Newswire (US)Flotek Announces Increased 2024 Guidance and Continued Profitability Growth in Connection with Second Quarter 2024 ResultsNYSE:FTKFlotek Industries Inc
06/08/202415:02PR Newswire (US)iRobot Names Jeffrey Engel as President & Chief Operating OfficerNASDAQ:IRBTiRobot Corporation
06/08/202415:02GlobeNewswire Inc.Inspire Medical Systems, Inc. Board Authorizes Share Repurchase ProgramNYSE:INSPInspire Medical Systems Inc
06/08/202415:02Business WireWynn Resorts, Limited Reports Second Quarter 2024 ResultsNASDAQ:WYNNWynn Resorts Ltd
06/08/202415:01GlobeNewswire Inc.MacroGenics Provides Update on Corporate Progress, Second Quarter 2024 Financial ResultsNASDAQ:MGNXMacroGenics Inc
06/08/202415:01GlobeNewswire Inc.Journey Medical Corporation to Announce Second Quarter 2024 Financial Results on August 12, 2024NASDAQ:DERMJourney Medical Corporation
06/08/202415:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ECVTEcovyst Inc
06/08/202415:01GlobeNewswire Inc.Sunrun Reports Second Quarter 2024 Financial ResultsNASDAQ:RUNSunrun Inc
06/08/202415:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CRVSCorvus Pharmaceuticals Inc
06/08/202415:01Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:NXUNXU Inc
06/08/202415:01Business WireVTEX Reports Second Quarter 2024 Financial ResultsNYSE:VTEXVTEX
06/08/202415:01Business WireGulfport Energy Reports Second Quarter 2024 Financial and Operating ResultsNYSE:GPORGulfport Energy Corporation
06/08/202415:01Business WireMindMed to Present at Canaccord Genuity’s 44th Annual Growth ConferenceNASDAQ:MNMDMind Medicine MindMed Inc
06/08/202415:01Business WireRobins Kaplan Appoints New Leadership for National Intellectual Property & Technology and Trial Groups
06/08/202415:01Business WirePower Integrations Reports Second-Quarter Financial ResultsNASDAQ:POWIPower Integrations Inc
06/08/202415:01Business WireSangamo Therapeutics Reports Recent Business Highlights and Second Quarter 2024 Financial ResultsNASDAQ:SGMOSangamo Therapeutics Inc
06/08/202415:01PR Newswire (US)Lumen Technologies reports second quarter 2024 resultsNYSE:LUMNLumen Technologies Inc
06/08/202415:01Business WireTempus Reports Second Quarter 2024 ResultsNASDAQ:TEMTempus AI Inc
06/08/202415:01PR Newswire (US)Axon reports Q2 2024 revenue of $504 million, up 35% year over year, raises outlookNASDAQ:AXONAxon Enterprise Inc
06/08/202415:01PR Newswire (US)AMGEN REPORTS SECOND QUARTER 2024 FINANCIAL RESULTSNASDAQ:AMGNAmgen Inc
06/08/202415:01PR Newswire (US)Dynavax Reports Second Quarter 2024 Financial Results and Provides Business UpdatesNASDAQ:DVAXDynavax Technologies Corp
06/08/202415:01PR Newswire (US)iRobot Reports Second-Quarter 2024 Financial ResultsNASDAQ:IRBTiRobot Corporation
06/08/202415:01PR Newswire (US)Precigen Strategically Prioritizes Portfolio to Focus on First Potential Gene Therapy LaunchNASDAQ:PGENPrecigen Inc